MaxLinear Q2 2024 Adj EPS $(0.25) Misses $(0.19) Estimate, Sales $91.990M Miss $100.044M Estimate
Portfolio Pulse from Benzinga Newsdesk
MaxLinear (NASDAQ:MXL) reported Q2 2024 adjusted EPS of $(0.25), missing the $(0.19) estimate by 31.58%. Sales were $91.990M, missing the $100.044M estimate by 8.05% and representing a 49.99% decrease from the same period last year.
July 24, 2024 | 8:27 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
MaxLinear reported Q2 2024 adjusted EPS of $(0.25), missing the $(0.19) estimate by 31.58%. Sales were $91.990M, missing the $100.044M estimate by 8.05% and representing a 49.99% decrease from the same period last year.
The significant miss on both EPS and sales estimates, coupled with a nearly 50% year-over-year decline in sales, is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100